Search - tctmd.com

Displaying 581 - 600 of 619

Sort: Relevancy | Date

News Industry News

Medtronic announces financial investment in Arsenal AAA, LLC

June 17, 2015

News Industry News

Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy

June 16, 2015

News Industry News

GORE® EXCLUDER® Conformable AAA Endoprosthesis Receives Approval for Clinical Study in the US and Japan

June 16, 2015

News Daily News

即便经验更丰富，经心尖TAVR带给患者的生活质量也并不好于外科手术

Caitlin E. Cox

June 15, 2015

News Industry News

TAVR program raises margin 350% by befriending rivals

June 15, 2015

News Daily News

Incluso con Más Experiencia la TAVR Transapical No ofrece una Mejor Calidad de Vida que la Cirugía

Caitlin E. Cox

June 15, 2015

News Daily News

Even With More Experience, Transapical TAVR Offers No Better QoL Than Surgery

Caitlin E. Cox

June 15, 2015

News Daily News

Los Índices de Episodios suelen estar Sobrevalorados en los Ensayos Cardiovasculares

Yael L. Maxwell

June 10, 2015

Presentation ARCH 2015

ARCH 2015 Keynote Address: The Future of Interventional Cardiology

Presenter: Martin B. Leon

April 10, 2015

News Features

Aunque Existe cierta Oposición, Crece el Apoyo a las Listas de Comprobación en el Laboratorio de Cateterismo

Caitlin E. Cox

April 03, 2015

News Daily News

Según un Estudio Británico los Pacientes que entran en Parada Cardíaca Extrahospitalaria se Benefician del Tratamiento Simplificado

February 17, 2015

News Daily News

La Afiliación Política de los Médicos es de Derechas pero se Aprecian Cambios

June 17, 2014

Presentation TVT 2014

A Citizen of the World and Frequent TAVR Proctor

Presenter: Eberhard Grube

June 07, 2014

Presentation TVT 2014

An Interventionalist from London, UK

Presenter: Martyn R. Thomas

June 07, 2014

Presentation TVT 2014

A Surgeon from Dallas, Texas

Presenter: Michael J. Mack

June 07, 2014

Presentation TVT 2014

The Daunting Task of Explaining High TAVR Costs to Practitioners, Hospital Administrators, and Healthcare Systems

Presenter: Larry L. Wood

June 07, 2014

Presentation TVT 2014

Are Reimbursement Patterns Directly Affecting TAVR Clinical Usage in Europe?

Presenter: Nicolo Piazza

June 07, 2014

Presentation TVT 2014

TAVR is not Cost Effective Compared with Surgery (in Most Patients)!

Presenter: A. Pieter Kappetein

June 07, 2014

Presentation TVT 2014

The TAVR Economic Value Proposition The Impact of Valve Costs, Complications, QOL Benefits, and Reimbursement Strategies

Presenter: David J. Cohen

June 07, 2014

Presentation TCT 2013

First Prize: Percutaneous Treatment of Aortic Annulus Rupture During Transcatheter Aortic Valve Implantation

Presenter: Andrea Pacchioni

November 01, 2013

Advertisement

Medtronic announces financial investment in Arsenal AAA, LLC

Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy

GORE® EXCLUDER® Conformable AAA Endoprosthesis Receives Approval for Clinical Study in the US and Japan

即便经验更丰富，经心尖TAVR带给患者的生活质量也并不好于外科手术

TAVR program raises margin 350% by befriending rivals

Incluso con Más Experiencia la TAVR Transapical No ofrece una Mejor Calidad de Vida que la Cirugía

Even With More Experience, Transapical TAVR Offers No Better QoL Than Surgery

Los Índices de Episodios suelen estar Sobrevalorados en los Ensayos Cardiovasculares

ARCH 2015 Keynote Address: The Future of Interventional Cardiology

Aunque Existe cierta Oposición, Crece el Apoyo a las Listas de Comprobación en el Laboratorio de Cateterismo

Según un Estudio Británico los Pacientes que entran en Parada Cardíaca Extrahospitalaria se Benefician del Tratamiento Simplificado

La Afiliación Política de los Médicos es de Derechas pero se Aprecian Cambios

A Citizen of the World and Frequent TAVR Proctor

An Interventionalist from London, UK

A Surgeon from Dallas, Texas

The Daunting Task of Explaining High TAVR Costs to Practitioners, Hospital Administrators, and Healthcare Systems

Are Reimbursement Patterns Directly Affecting TAVR Clinical Usage in Europe?

TAVR is not Cost Effective Compared with Surgery (in Most Patients)!

The TAVR Economic Value Proposition The Impact of Valve Costs, Complications, QOL Benefits, and Reimbursement Strategies

First Prize: Percutaneous Treatment of Aortic Annulus Rupture During Transcatheter Aortic Valve Implantation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content